These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

57 related items for PubMed ID: 18039725

  • 1. Intensification of therapy and no increase in body mass index with longer disease duration in type 2 diabetes mellitus (ZODIAC-5).
    Logtenberg SJ, Kleefstra N, Ubink-Veltmaat LJ, Houweling ST, Bilo HJ.
    Fam Pract; 2007 Dec; 24(6):529-31. PubMed ID: 18039725
    [Abstract] [Full Text] [Related]

  • 2. Beta-cell function and mass in type 2 diabetes.
    Larsen MO.
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [Abstract] [Full Text] [Related]

  • 3. [Differences between diabetes mellitus type 2 patients switched and not switched over to insulin treatment after specialist consultation].
    Goddijn PP, Meyboom-de Jong B, Feskens EJ, van Ballegooie E, Bilo HJ.
    Ned Tijdschr Geneeskd; 1998 May 02; 142(18):1023-6. PubMed ID: 9623204
    [Abstract] [Full Text] [Related]

  • 4. Weight gain in type 2 diabetes mellitus--not all uphill.
    Cohen O, Norymberg C, Neumann E, Dekel H.
    Diabetes Res Clin Pract; 2008 Jan 02; 79(1):128-32. PubMed ID: 17720273
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of chronic kidney disease in type 2 diabetes in primary health care unit of Udon Thani province, Thailand.
    Narenpitak S, Narenpitak A.
    J Med Assoc Thai; 2008 Oct 02; 91(10):1505-13. PubMed ID: 18972892
    [Abstract] [Full Text] [Related]

  • 6. Type 2 diabetes in primary care in belgium: need for structured shared care.
    Goderis G, Borgermans L, Heyrman J, Broeke CV, Grol R, Boland B, Mathieu C.
    Exp Clin Endocrinol Diabetes; 2009 Sep 02; 117(8):367-72. PubMed ID: 19358093
    [Abstract] [Full Text] [Related]

  • 7. Association of leptin with insulin resistance, body composition, and lipid parameters in postmenopausal women and men in type 2 diabetes mellitus.
    Gulturk S, Cetin A, Erdal S.
    Saudi Med J; 2008 Jun 02; 29(6):813-20. PubMed ID: 18521457
    [Abstract] [Full Text] [Related]

  • 8. Risk of development of chronic kidney disease in patients with type 2 diabetes having metabolic syndrome.
    Moin S, Gondal GM, Bano U.
    J Coll Physicians Surg Pak; 2008 Aug 02; 18(8):472-6. PubMed ID: 18798582
    [Abstract] [Full Text] [Related]

  • 9. Gastric banding for the treatment of type 2 diabetes mellitus in morbidly obese.
    Brancatisano A, Wahlroos S, Matthews S, Brancatisano R.
    Surg Obes Relat Dis; 2008 Aug 02; 4(3):423-9. PubMed ID: 18226973
    [Abstract] [Full Text] [Related]

  • 10. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E, Minuto F, Colao A, Ferone D.
    Acta Diabetol; 2009 Jun 02; 46(2):85-95. PubMed ID: 19322513
    [Abstract] [Full Text] [Related]

  • 11. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK.
    J Am Pharm Assoc (2003); 2009 Jun 02; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [Abstract] [Full Text] [Related]

  • 12. Initiating insulin in patients with type 2 diabetes.
    Aoki TJ, White RD.
    J Fam Pract; 2007 Aug 02; 56(8 Suppl Hot Topics):S12-20. PubMed ID: 18667139
    [Abstract] [Full Text] [Related]

  • 13. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
    Ruge T, Lockton JA, Renstrom F, Lystig T, Sukonina V, Svensson MK, Eriksson JW.
    Metabolism; 2009 Jun 02; 58(6):860-6. PubMed ID: 19375766
    [Abstract] [Full Text] [Related]

  • 14. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A, Sämann A, Kubiak T, Zieschang T, Kloos C, Müller UA, Oster P, Wolf G, Schiel R.
    Patient Educ Couns; 2008 Oct 02; 73(1):50-9. PubMed ID: 18583087
    [Abstract] [Full Text] [Related]

  • 15. Increased cancer mortality in type 2 diabetes (ZODIAC-3).
    Landman GW, Ubink-Veltmaat LJ, Kleefstra N, Kollen BJ, Bilo HJ.
    Anticancer Res; 2008 Oct 02; 28(2B):1373-5. PubMed ID: 18505082
    [Abstract] [Full Text] [Related]

  • 16. Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study.
    Dornhorst A, Lüddeke HJ, Sreenan S, Kozlovski P, Hansen JB, Looij BJ, Meneghini L, PREDICTIVE Study Group.
    Int J Clin Pract; 2008 Apr 02; 62(4):659-65. PubMed ID: 18324957
    [Abstract] [Full Text] [Related]

  • 17. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
    Kadera BE, Lum K, Grant J, Pryor AD, Portenier DD, DeMaria EJ.
    Surg Obes Relat Dis; 2009 Apr 02; 5(3):305-9. PubMed ID: 19460674
    [Abstract] [Full Text] [Related]

  • 18. Association of TCF7L2 polymorphism with diabetes mellitus, metabolic syndrome, and markers of beta cell function and insulin resistance in a population-based sample of Emirati subjects.
    Saadi H, Nagelkerke N, Carruthers SG, Benedict S, Abdulkhalek S, Reed R, Lukic M, Nicholls MG.
    Diabetes Res Clin Pract; 2008 Jun 02; 80(3):392-8. PubMed ID: 18282631
    [Abstract] [Full Text] [Related]

  • 19. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, D'Angelo A, Cicero AF.
    Metabolism; 2009 Aug 02; 58(8):1059-66. PubMed ID: 19394976
    [Abstract] [Full Text] [Related]

  • 20. Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes.
    Mojiminiyi OA, Marouf R, Abdella NA.
    Nutr Metab Cardiovasc Dis; 2008 Oct 02; 18(8):559-66. PubMed ID: 18063352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.